PSMD1 and COVID-19: If 97.2% of the second sample collection (sample 2) occurred before the start of the SARS-CoV2 vaccination campaign in Switzerland (28/12/2020), 100% (12/12) of the anti-S1 positive patients were unvaccinated, implying a COVID-19-induced S1 seroconversion.